Advertisement

Topics

Latest "Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma" News Stories

02:46 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma" found in our extensive news archives from over 250 global news sources.

More Information about Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma for you to read. Along with our medical data and news we also list Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Companies for you to search.

Showing "Genetic Study Patients With Acute Myeloid Leukemia Acute" News Articles 1–25 of 40,000+

Friday 22nd March 2019

Xiangxue Approved to Start China Trial of T-Cell Therapy for Solid Tumors

Guangzhou Xiangxue Life Sciences (XLifeSc), a subsidiary of Xiangxue Pharmaceutical, was approved by China's NMPA to start clinical studies of its T-cell receptor Affinity Enhanced Specific T-cell (TAEST) therapy in patients with solid tumors. Earlier, XLifeSc announced positive results from a small pilot study of the TAEST thrapy in China. Xiangxue in-licensed the therapy from Athenex, a New York...


I-Mab Starts Greater China Trials of CD38 Antibody for Myeloma

I-Mab Biopharma, a Shanghai company focused on immuno-oncology and autoimmune diseases, dosed the first patient in a Phase II Taiwan trial of a CD38 antibody in patients with relapsed or refractory multiple myeloma. In 2017, I-Mab acquired greater China rights to TJ202/MOR202 from MorphoSys AG in a $120 million deal. The multi-center trial, which will also include mainland China sites, is designed...

Thursday 21st March 2019

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes


For decades, this rare disease had no treatment or even a biological explanation. But thanks to a well-organized patient group, dedicated researchers, and scientific serendipity, the future for these patients is unprecedentedly bright. https://buff.ly/2Cq

For decades, this rare disease had no treatment or even a biological explanation. But thanks to a well-organized patient group, dedicated researchers, and scientific serendipity, the future for these patients is unprecedentedly bright. https://buff.ly/2CqOwQ8 

Pesticide Exposure Linked with Autism in Epidemiological Study http://ow.ly/UJe730o8rSk pic.twitter.com/Tl9XnYIVqm

Pesticide Exposure Linked with Autism in Epidemiological Study http://ow.ly/UJe730o8rSk  pic.twitter.com/Tl9XnYIVqm

Spinal sagittal alignment and trapezoidal deformity in patients with degenerative cervical spondylolisthesis

Breast cancer metastasis is shown to be associated with increased levels of stress hormones in a mouse study reported in Nature. https://go.nature.com/2Fc9owu pic.twitter.com/FPBk51gEvk

Breast cancer metastasis is shown to be associated with increased levels of stress hormones in a mouse study reported in Nature. https://go.nature.com/2Fc9owu  pic.twitter.com/FPBk51gEvk

Some 30% of childhood cancer survivors will be infertile. A new study suggests it might be possible to save a piece of a boy’s testicular tissue and later coax it to produce mature sperm. https://buff.ly/2Cx588Z pic.twitter.com/eWdfL4xN3k

Some 30% of childhood cancer survivors will be infertile. A new study suggests it might be possible to save a piece of a boy’s testicular tissue and later coax it to produce mature sperm. https://buff.ly/2Cx588Z  pic.twitter.com/eWdfL4xN3k

bacteria identification, fatty acid analysis, biological testing, DNA sequencing, genetic analysis, strain tracking

Provider of, microbial analysis, microbial identification, biological testing, DNA sequencing, aerobic bacteria, sherlock, anaerobic bacteria

Doctors say Kentucky Gov. Matt Bevin is wrong about chickenpox

Intentionally exposing children to the virus hurts public health efforts and risks dangerous complications in some patients, experts say.

BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease

STOCKHOLM, Sweden, March 21, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that its partner Eisai has initiated the global Phase 3 confirmatory study of BAN24...

There may be a way to keep CRISPR'd cells from becoming cancerous, a new study shows. https://buff.ly/2FmN6GY 

There may be a way to keep CRISPR'd cells from becoming cancerous, a new study shows. https://buff.ly/2FmN6GY 

Multiple links between stress and breast cancer progression

In mid-February, a study led by Chinese researchers established that the stress hormone epinephrine sets off a cascade of biochemical reactions that favour breast cancer growth and spread. Their work was published in The Journal of Clinical Investigation. The researchers first demonstrated the effects of chronic stress on cancer stem cell growth, in a twist on previous research that did not speci...

Testosterone Limits for Female Athletes Not Backed by Science, Say Academics

(The Guardian) – Proposed regulations on testosterone levels in women’s athletics have been criticised by academics who say they are not backed by scientific evidence and risk opening a pandora’s box on genetic advantages in sport. The International Association of … Read More

Popular Health Apps Share Data with Third Parties, Study Shows

(UPI) – The widespread use of mobile health apps can help more people locate prescriptions and remember to take pills. But this technology also opens people up to have all of that medical information passed along to third parties without … Read More

Turning Point Therapeutics Files Registration Statement for Proposed Initial Public Offering

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) relating to a proposed initial public offering of common stock. The number of shares to be off...

CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)

SUZHOU, China, March 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that China's National Medical Products Administration (NMPA) has approved the clinical trial application to begin a Phase 1 trial in China for BLU-667 (CS3009), a highly selective and potent RET inhibitor discovered by CStone's partner Blueprint Medicines. The study is part of Blue...

Two-drug combos built around amlodipine control BP in African study

Study Finds Cancer Drugs Can be Repurposed Beyond Known Uses

The drug sorafenib (Nexavar®) typically used for kidney and liver cancer treatment provided complete remission for breast cancer patient after lab discoveries In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to ...

IMV Inc. Announces 2018 Year-end Financial and Operational Results and Provides Updates on Key Clinical Programs

Attained multiple milestones in DECIDE1/2 clinical program in advanced ovarian cancer Achieved initial positive data from phase 2 clinical trial in DLBCL with Merck Initiated a phase 2 basket trial across five indications under a collaboration with Merck Listed on Nasdaq and changed Corpora...

DO SMARTPHONE APPS HELP KIDNEY DISEASE PATIENTS MANAGE THEIR DISEASE?

Very few apps related to chronic kidney disease are highly rated by patients or physicians Patient ratings of smartphone apps related to managing kidney disease correlated poorly with both physician ratings and consumer ratings.

STUDIES EXAMINE WAYS TO ASSESS QUALITY OF LIFE IN PATIENTS WITH KIDNEY DISEASE.

Two new studies provide insights on how physicians can effectively and efficiently evaluate patient-reported outcomes and health-related quality of life in individuals with kidney disease.

Breast ultrasound and cancer detection rates increased under new laws

State breast density notification laws that mandate reporting of mammogram results can prompt further screening and modestly boost cancer detection rates, say researchers at Yale's School of Public Health and School of Medicine. Their study was published...

Leveraging Limited Data in Metastatic Pancreatic Cancer

Damian Laber, MD, provides a brief history of the trials that led to current frontline and second-line standards for patients with metastatic pancreatic cancer and shares his hope for the future of the treatment paradigm.

From our senior leaders to our scientists working to discover new treatments to our manufacturing teams ensuring the highest standards of quality, every Pfizer colleague approaches our work with #PatientsatOurCenter. It’s how we deliver breakthroughs th

From our senior leaders to our scientists working to discover new treatments to our manufacturing teams ensuring the highest standards of quality, every Pfizer colleague approaches our work with #PatientsatOurCenter. It’s how we deliver breakthroughs that change patients’ lives.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks